Synthesis of new hypoxia markers EF1 and [18F]-EF1

Applied Radiation and Isotopes

Volumn 51, Issue 6, 1999, Pages 643-650

  Kachur, Alexander V ^a   Dolbier Jr , William R ^b   Evans, Sydney M ^a   Shiue, Chyng Yann ^a   Shiue, Grace G ^a   Skov, Kirsten A ^c   Baird, Ian R ^d   James, Brian R ^d   Li, An Rong ^b   Roche, Alex ^b   Koch, Cameron J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Sch of Med Univ of Pennsylvania ^*  (United States)

^c BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORINE COMPOUNDS; NITROGEN COMPOUNDS; NONINVASIVE MEDICAL PROCEDURES; POSITRON EMISSION TOMOGRAPHY; RADIATION CHEMISTRY; SYNTHESIS (CHEMICAL);

HYPOXIA MARKERS;

RADIOACTIVE TRACERS;

NITROIMIDAZOLE DERIVATIVE;

ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOXIA; METHODOLOGY; NONHUMAN; PRIORITY JOURNAL; RADIOISOTOPE DIAGNOSIS;

ANOXIA; BIOLOGICAL MARKERS; FLUORINE RADIOISOTOPES; ISOTOPE LABELING; NITROIMIDAZOLES; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033486390     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8043(99)00096-2     Document Type: Article

References (33)

1. Brizel D.M., Sibley G.S., Prosnitz L.R., Scher R.L., Dewhirst M.W. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. International Journal of Radiation Oncology, Biology, Physics. 38:(2):1997;285-289.
2. Chapman J.D., Garrech B., Baer K., Meeker B.E. The Development of Radioactive Sensitizers as Markers for Hypoxic Cells in Tumors. 1983;Martinus Nijhoft, Amsterdam, Netherlands.
3. 131I]Iodoerythronitroimidazole. Journal of Drug Targeting. 4:(1):1996;31-39.
4. Cook G.J., Houston S., Barrington S.F., Fogelman I. Technetium-99m-labeled HL91 to identify tumor hypoxia: correlation with fluorine-18-FDG. Journal of Nuclear Medicine. 39:(1):1998;99-103.
5. Evans S.M., Joiner B., Jenkins W.T., Laughlin K.M., Lord E.M., Koch C.J. Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide]. British Journal of Cancer. 72:(4):1995;875-882.
6. Gibson M., Bradshaw R. The Gabriel synthesis of primary amines. Angewandte Chemie, International Edition in English. 7:1968;919-930.
7. Grierson J.R., Link J.M., Mathis C.A., Rasey J.S., Krohn K.A. A radiosynthesis of fluorine-18 fluoromisonidazole. Journal of Nuclear Medicine. 30:(3):1989;343-350.
8. Groshar D., McEwan A.J., Parliament M.B., Urtasun R.C., Golberg L.E., Hoskinson M., Mercer J.R., Mannan R.H., Wiebe L.I., Chapman J.D. Imaging tumor hypoxia and tumor perfusion. Journal of Nuclear Medicine. 34:(6):1993;885-888.
9. 18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. Journal of Nuclear Medicine. 27:(2):1986;235-238.
10. 2 predicts survival in advanced cancer of the uterine cervix. Radiotherapy and Oncology. 26:(1):1993;45-50.
11. 18F-labeled fluoronitroimidazoles: potential in vivo markers of hypoxic tissue. International Journal of Radiation Applications and Instrumentation A. 37:(7):1986;599-605.
12. 82Br]bromomisonidazole. International Journal of Nuclear Medicine and Biology. 10:(4):1983;205-210.
13. Kilbourn M. Fluorine-18 labelling of Radiopharmaceuticals. 1990;150 National Academy Press, Washington, DC.
14. Koch C.J., Stobbe C.C., Baer K.A. Metabolism induced binding of 14C-misonidazole to hypoxic cells: kinetic dependence on oxygen concentration and misonidazole concentration. International Journal of Radiation Oncology, Biology, Physics. 10:1984;1327-1332.
15. Koch C.J., Evans S.M., Lord E.M. Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide]: analysis of drug adducts by fluorescent antibodies vs bound radioactivity. British Journal of Cancer. 72:(4):1995;869-874.
16. Koh W.J., Rasey J.S., Evans M.L., Grierson J.R., Lewellen T.K., Graham M.M., Krohn K.A., Griffin T.W. Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole. International Journal of Radiation Oncology, Biology, Physics. 22:(1):1992;199-212.
17. Koh W.J., Griffin T.W., Rasey J.S., Laramore G.E. Positron emission tomography. A new tool for characterization of malignant disease and selection of therapy. Acta Oncologica. 33:(3):1994;323-327.
18. Krejcarek G.E., Tucker K.L. Covalent attachment of chelating groups to macromolecules. Biochemical and Biophysical Research Communications. 77:(2):1977;581-585.
19. Linder K., Chan Y., Cyr J., Malley M., Nowotnik D., Nunn A. TcO(PnA-O-1-(2-nitroimidaxzole)) [BMS-181321] a new technetium containing nitroimidazole complex for imaging hypoxia: synthesis, characterization, and xanthine oxidase catalyzed reduction. Journal of Medicinal Chemistry. 37:(1):1994;9-17.
20. Lord E.M., Harwell L., Koch C.J. Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts. Cancer Research. 53:1993;5721-5726.
21. Mannan R.H., Mercer J.R., Wiebe L.I., Somayaji V.V., Chapman J.D. Radioiodinated 1-(2-fluoro-4-iodo-2,4-dideoxy-beta-L-xylopyranosyl)-2-nitroimidazole: a novel probe for the noninvasive assessment of tumor hypoxia. Radiation Research. 132:(3):1992;368-374.
22. Mathias C.J., Welch M.J., Kilbourn M.R., Jerabek P.A., Patrick T.B., Raichle M.E., Krohn K.A., Rasey J.S., Shaw D.W. Radiolabeled hypoxic cell sensitizers: tracers for assessment of ischemia. Life Sciences. 41:(2):1987;199-206.
23. Nordsmark M., Overgaard M., Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiotherapy and Oncology. 41:(1):1996;31-39.
24. 99mTc-HL91. Effects of low flow and hypoxia on a new ischemia-avid myocardial imaging agent. Circulation. 95:(7):1997;1892-1899.
25. 123I-iodoazomycin arabinoside: preliminary report of a clinical study. British Journal of Cancer. 65:(1):1992;90-95.
26. Rasey J.S., Grunbaum Z., Magee S., Nelson N.J., Olive P.L., Durand R.E., Krohn K.A. Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells. Radiation Research. 111:(2):1987;292-304.
27. Sheehan J., Ryan J. The synthesis of substituted penicillins and simpler structural analogs. (I) alpha amino monocyclic beta lactams. Journal of the American Chemical Society. 73:1951;1206.
28. 18F]fluoroetanidazole: a potential new tracer for imaging hypoxia. Nuclear Medicine and Biology. 24:(8):1997;755-760.
29. Valk P.E., Mathis C.A., Prados M.D., Gilbert J.C., Budinger T.F. Hypoxia in human gliomas: demonstration by PET with fluorine-18-fluoromisonidazole. Journal of Nuclear Medicine. 33:(12):1992;2133-2137.
30. Varghese A.J., Gulyas S., Mohindra J.K. Hypoxia-dependent reduction of 1-(2-nitro-1-imidazolyl)-3-methoxy-2-propanol by Chinese hamster ovary cells and KHT tumor cells in vitro and in vivo. Cancer Research. 36:1976;3761-3765.
31. Wiebe L.I., Stypinski D. Pharmacokinetics of SPECT radiopharmaceuticals for imaging hypoxic tissues. Quarterly Journal of Nuclear Medicine. 40:(3):1996;270-284.
32. Yang D.J., Wallace S., Cherif A., Li C., Gretzer M.B., Kim E.E., Podoloff D.A. Development of F-18-labeled fluoroerythronitroimidazole as a PET agent for imaging tumor hypoxia. Radiology. 194:(3):1995;795-800.
33. Yeh S.H., Liu R.S., Wu L.C., Yang D.J., Yen S.H., Chang C.W., Yu T.W., Chou K.L., Chen K.Y. Fluorine-18 fluoromisonidazole tumour to muscle retention ratio for the detection of hypoxia in nasopharyngeal carcinoma. European Journal of Nuclear Medicine. 23:(10):1996;1378-1383.